Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • RESEARCH HIGHLIGHT

Combination treatment for immune-mediated HIV remission

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41591-024-00020-6

UPDATES & CORRECTIONS

Correction 02 April 2024: In the version of this Research Highlight originally published, the number of study animals and doses noted were incorrect. The sentence that originally read “Thirteen animals were treated with N-803 (six weekly subcutaneous doses) plus bNAbs (two infusion doses), after which ART was discontinued” has now been corrected, to read “In the second of two macaque studies, sixteen animals were treated with N-803 (six weekly doses) plus bNAbs (three infusion doses), after which ART was discontinued.”

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links